We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

192 hedge funds and large institutions have $6.65B invested in BeOne Medicines Ltd in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 32

140% more call options, than puts

Call options by funds: $50.8M | Put options by funds: $21.1M

117% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 30

56% more funds holding in top 10

Funds holding in top 10: 9 → 14 (+5)

33% more funds holding

Funds holding: 144 → 192 (+48)

0.23% more ownership

Funds ownership: 5.95% → 6.18% (+0.23%)

15% less capital invested

Capital invested by funds: $7.84B → $6.65B (-$1.19B)

Holders
192
Holders Change
+48
Holders Change %
+33.33%
% of All Funds
4.28%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.31%
New
82
Increased
65
Reduced
30
Closed
32
Calls
$50.8M
Puts
$21.1M
Net Calls
+$29.6M
Net Calls Change
+$49.2M

Top Buyers

1
BlackRock
BlackRock
New York
+$186M
2
Capital International Investors
Capital International Investors
California
+$136M
3
Northern Trust
Northern Trust
Illinois
+$74.8M
4
State Street
State Street
Massachusetts
+$68.8M
5
CGT
Capital Guardian Trust
California
+$44.9M

Top Sellers

1
HIM
Hillhouse Investment Management
Cayman Islands
-$589M
2
HSBC Holdings
HSBC Holdings
United Kingdom
-$348M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$315M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$44.4M
5
Renaissance Technologies
Renaissance Technologies
New York
-$24.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$39.2M +$978K +7,372 +3%
Deutsche Bank
27
Deutsche Bank
Germany
$35.3M -$11.1M -83,546 -25%
Sands Capital Management
28
Sands Capital Management
Virginia
$34.4M +$20.1M +151,354 +161%
MICM
29
Matthews International Capital Management
California
$34.1M +$4.81M +36,300 +18%
Rockefeller Capital Management
30
Rockefeller Capital Management
New York
$32.1M +$27.1M +204,621 +852%
Victory Capital Management
31
Victory Capital Management
Texas
$31.5M +$8.88M +66,950 +42%
Fiera Capital (Canada)
32
Fiera Capital (Canada)
Quebec, Canada
$30.2M +$27.8M +209,568 +3,554%
RSCM
33
Rock Springs Capital Management
Maryland
$30.1M -$26.5K -200 -0.1%
CII
34
Capital International Inc
California
$27.4M +$25.9M +195,672 New
Legal & General Group
35
Legal & General Group
United Kingdom
$24.4M +$11.5M +86,355 +99%
MAM
36
Myriad Asset Management
Hong Kong
$23.3M +$22M +165,800 New
PC
37
Polar Capital
United Kingdom
$22.4M +$9.95M +75,000 +88%
WRF
38
Waddell & Reed Financial
Kansas
$22.2M – – –
CS
39
Candriam SCA
Luxembourg
$20.7M +$6.3M +47,488 +47%
ICP
40
Indus Capital Partners
New York
$19.4M -$9.06M -68,325 -33%
Sumitomo Mitsui Trust Group
41
Sumitomo Mitsui Trust Group
Japan
$19.1M +$18.5M +139,355 New
Geode Capital Management
42
Geode Capital Management
Massachusetts
$18.6M +$14.4M +108,218 +419%
B
43
Barings
North Carolina
$18.3M +$4.23M +31,915 +32%
Swiss National Bank
44
Swiss National Bank
Switzerland
$16.7M +$15.8M +119,300 New
CS
45
Credit Suisse
Switzerland
$16.4M +$8.18M +61,721 +112%
Macquarie Group
46
Macquarie Group
Australia
$15.7M +$119K +900 +0.8%
Bank of America
47
Bank of America
North Carolina
$15.2M -$1.77M -13,333 -11%
UBS AM
48
UBS AM
Illinois
$14.5M +$13M +98,082 +1,886%
Nordea Investment Management
49
Nordea Investment Management
Sweden
$14.1M +$3.52M +26,568 +36%
HFM
50
Harvest Fund Management
China
$14M – – –
1
2
3 4 5

ONC Hedge Fund Activity: Q4 2018 in Review

192 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2018, worth a combined $6.65B — down 15% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new ONC positions and 32 closed out — a net gain of 50 holders — while 65 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $186M. The largest seller was Hillhouse Investment Management, cutting an estimated $589M.

  • 192 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2018, up from 144 in Q3 2018.
  • Funds reported $6.65B of BeOne Medicines Ltd stock for Q4 2018, down 15% quarter-over-quarter.
  • 82 funds opened new BeOne Medicines Ltd positions in Q4 2018 and 32 closed out, a net change of +50 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2018 was BlackRock, an estimated $186M added.
  • The largest BeOne Medicines Ltd seller in Q4 2018 was Hillhouse Investment Management, an estimated $589M sold.

Based on aggregated 13F filings for Q4 2018.